We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BP icon
301
BP
BP
$113B
$10.7M 0.08%
359,150
+350
+0.1% +$10.3K
FWONA icon
302
Liberty Media Series A
FWONA
$22.3B
$10.7M 0.08%
112,750
-2,400
-2% -$203K
WRB icon
303
W.R. Berkley
WRB
$28B
$10.7M 0.08%
145,348
-3,124
-2% -$224K
SNV
304
DELISTED
Synovus
SNV
$10.6M 0.08%
205,016
+128,816
+169% +$5.92M
LBTYK icon
305
Liberty Global Class C
LBTYK
$3.27B
$10.6M 0.08%
1,028,264
-86,000
-8% -$891K
ZBH icon
306
Zimmer Biomet
ZBH
$17.7B
$10.5M 0.07%
115,450
+4,500
+4% +$435K
VMC icon
307
Vulcan Materials
VMC
$36.3B
$10.5M 0.07%
40,310
+5,810
+17% +$1.49M
ADM icon
308
Archer Daniels Midland
ADM
$41.4B
$10.5M 0.07%
198,600
-3,800
-2% -$185K
RES icon
309
RPC Inc
RES
$1.24B
$10.4M 0.07%
2,207,477
-61,938
-3% -$298K
ORLA
310
Orla Mining
ORLA
$3.48B
$10.3M 0.07%
1,025,800
+525,800
+105% +$5.47M
VOD icon
311
Vodafone
VOD
$34.9B
$10.2M 0.07%
960,300
-1,500
-0.2% -$14.5K
TMO icon
312
Thermo Fisher Scientific
TMO
$211B
$10.2M 0.07%
25,035
– –
ICUI icon
313
ICU Medical
ICUI
$3.93B
$10.1M 0.07%
76,500
+6,000
+9% +$813K
MTB icon
314
M&T Bank
MTB
$36.2B
$10.1M 0.07%
51,907
-1,158
-2% -$204K
ECHO
315
EchoStar
ECHO
$25.5B
$9.97M 0.07%
359,805
+70,000
+24% +$1.54M
DVN icon
316
Devon Energy
DVN
$51.9B
$9.83M 0.07%
309,000
-4,400
-1% -$140K
VLO icon
317
Valero Energy
VLO
$89.8B
$9.82M 0.07%
73,077
+9,677
+15% +$1.21M
TAP icon
318
Molson Coors Class B
TAP
$7.68B
$9.77M 0.07%
203,232
+62,632
+45% +$3.45M
ODC icon
319
Oil-Dri
ODC
$1.43B
$9.69M 0.07%
164,200
-1,000
-0.6% -$48.5K
ESGR
320
DELISTED
Enstar Group
ESGR
$9.67M 0.07%
28,763
– –
TG icon
321
Tredegar Corp
TG
$268M
$9.62M 0.07%
1,093,615
-3,600
-0.3% -$29K
NVS icon
322
Novartis
NVS
$295B
$9.61M 0.07%
79,400
-500
-0.6% -$56.4K
BIO icon
323
Bio-Rad Laboratories Class A
BIO
$8.42B
$9.6M 0.07%
39,800
-500
-1% -$118K
BWA icon
324
BorgWarner
BWA
$13.2B
$9.46M 0.07%
282,500
-6,500
-2% -$199K
VIGL
325
DELISTED
Vigil Neuroscience
VIGL
$9.46M 0.07%
+1,189,528
New +$5.33M
11 12
13
14 15

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.